Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
130.7 USD | +2.93% | +4.38% | +19.90% |
01:44pm | Truist Lifts Price Target on Merck to $143 From $142, Keeps Buy Rating | MT |
01:36pm | AbbVie raises annual profit forecast on strong Skyrizi sales | RE |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+19.90% | 331B | |
+24.35% | 653B | |
+25.38% | 556B | |
-6.33% | 354B | |
+7.95% | 296B | |
+12.79% | 233B | |
+5.33% | 201B | |
-10.02% | 193B | |
-6.47% | 144B | |
-12.26% | 143B |
- Stock Market
- Equities
- MRK Stock
- News Merck & Co., Inc.
- Transcript : Merck & Co., Inc. - Shareholder/Analyst Call